Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gut microbiome alpha-diversity is not a marker of Parkinson’s disease and multiple sclerosis

1 Apr 2021

Abstract excerpt

Abstract The gut–brain axis may play a central role in the pathogenesis of neurological disorders. Dozens of case–control studies have been carried out to identify bacterial markers by the use of targeted metagenomics. Alterations of several taxonomic profiles have been confirmed across several populations, however, no consensus has been made regarding alpha-diversity. A recent publication has described and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dysphagia Assessment and Management
Share to Gut microbiota and health
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34704023
DOI: 10.1093/braincomms/fcab113

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gut microbiome alpha-diversity is not a marker of Parkinson’s disease and multiple sclerosisPMID 34704023Read ↗

Leveraging sequence‐based faecal microbial community survey data to identify alterations in gut microbiota among patients with Parkinson's diseaseSemantic proximity Read ↗

Gut microbiota, 1013 new pieces in the Parkinson's disease puzzleSemantic proximity Read ↗

Microbial Diversity in Drug Naïve Parkinson’s Disease PatientsSemantic proximity Read ↗

Gut microbiome in Parkinson's disease: New insights from meta-analysisSemantic proximity Read ↗

Meta-analysis of the gut microbiome of Parkinson’s disease patients suggests alterations linked to intestinal inflammationSemantic proximity Read ↗

Gut Vibes in Parkinson's Disease: The Microbiota‐Gut‐Brain AxisSemantic proximity Read ↗

Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanismsSemantic proximity Read ↗

Analysis of Gut Microbiota in Patients with Parkinson’s DiseaseSemantic proximity Read ↗

Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical featuresSemantic proximity Read ↗

A meta-study of the microbiome and related dysfunction of the brain reveals distinct microbial signatures in the microbiota-gut-brain axisSemantic proximity Read ↗

Microbiome-based biomarkers to guide personalized microbiome-based therapies for Parkinson’s diseaseSemantic proximity Read ↗

Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.